Evidence map›Paper›PMID 37877355›Full record

ArticleChemical communications (Cambridge, England)2023

Development of

Muyun Xu, Xinrui Ma, Jessica E Pigga, He Zhang, Shuli Wang, Weiling Zhao, Huaifu Deng, Anna M Wu, Rihe Liu, Zhanhong Wu and 2 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical communications (Cambridge, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Muyun XuDepartment of Radiology, Biomedical Research Imaging Center, and Lineberger Comprehensive Cancer Center, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. zhanhong_wu@med.unc.edu.ORCID http://orcid.org/0000-0003-4904-332X
Xinrui MaDepartment of Radiology, Biomedical Research Imaging Center, and Lineberger Comprehensive Cancer Center, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. zhanhong_wu@med.unc.edu.ORCID http://orcid.org/0000-0002-7970-3387
Jessica E PiggaDepartment of Chemistry, the University of Delaware, Newark, Delaware, 19716, USA. jmfox@udel.edu.
He ZhangDepartment of Radiology, Biomedical Research Imaging Center, and Lineberger Comprehensive Cancer Center, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. zhanhong_wu@med.unc.edu.
Shuli WangDepartment of Radiology, Biomedical Research Imaging Center, and Lineberger Comprehensive Cancer Center, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. zhanhong_wu@med.unc.edu.
Weiling ZhaoDepartment of Radiology, Biomedical Research Imaging Center, and Lineberger Comprehensive Cancer Center, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. zhanhong_wu@med.unc.edu.
Huaifu DengDepartment of Radiology, Biomedical Research Imaging Center, and Lineberger Comprehensive Cancer Center, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. zhanhong_wu@med.unc.edu.
Anna M WuDepartment of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope, Duarte, California, 91010, USA.
Rihe LiuDivision of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Zhanhong WuDepartment of Radiology, Biomedical Research Imaging Center, and Lineberger Comprehensive Cancer Center, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. zhanhong_wu@med.unc.edu.
Joseph M FoxDepartment of Chemistry, the University of Delaware, Newark, Delaware, 19716, USA. jmfox@udel.edu.ORCID http://orcid.org/0000-0002-8258-1640
Zibo LiDepartment of Radiology, Biomedical Research Imaging Center, and Lineberger Comprehensive Cancer Center, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. zhanhong_wu@med.unc.edu.ORCID http://orcid.org/0000-0002-1063-0298
University of North Carolina at Chapel Hill · USUniversity of Delaware · USCity of Hope · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
This renovation project will create over 1455 sq. ft. of state- of-the-art reseaP20GM104316 · NIGMS · UNIVERSITY OF DELAWARE · PI SCHMITZ, KARL ROBERT · 2014 to 2024
$26.8M
Toolkit for Fast, Multipurpose and Inducible Bioorthogonal ChemistryR01GM132460 · NIGMS · UNIVERSITY OF DELAWARE · PI JOSEPH M FOX · 2019 to 2026
$4.2M
Novel Catalytic Methods for Efficient Radiolabeling of Un-activated Arene Compounds SupplementR01EB029451 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, ZIBO, NICEWICZ, DAVID A · 2020 to 2023
$2.2M
The development of novel PET/NIRF agents for hyperparathyroidism managementR01DK128447 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KIM, LAWRENCE THOMAS, WU, ZHANHONG · 2021 to 2024
$2.0M
Development of IDO PET agents for immunotherapyR01CA233904 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, ZIBO, MOSCHOS, STERGIOS · 2019 to 2023
$2.0M
High Sensitivity NMR Spectrometer with CryoprobeS10OD025185 · OD · UNIVERSITY OF DELAWARE · PI FOX, JOSEPH M · 2019 to 2019
$930k
Small Animal PET/CT for Preclinical Imaging ResearchS10OD023611 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, ZIBO · 2017 to 2017
$835k
High Performance Digital NMR SpectrometerS10RR026962 · NCRR · UNIVERSITY OF DELAWARE · PI FOX, JOSEPH M · 2010 to 2010
$500k
NCI NIH HHS P30 CA016086NCI NIH HHS R01 CA233904NCRR NIH HHS S10 RR026962NIBIB NIH HHS R01 EB029451NIDDK NIH HHS R01 DK128447NIGMS NIH HHS P20 GM104316NIGMS NIH HHS R01 GM132460NIH HHS S10 OD023611NIH HHS S10 OD025185
6 · The paper itself

Abstract

We report the development of a hydrophilic

Indexed as

CyclooctanesPositron-Emission TomographyCell Line, TumorFluorine RadioisotopesCyclooctanesFluorine Radioisotopes

Identifiers

PMID37877355
PMCPMC10785124
OpenAlexW4387718763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.